Skip to main content
. 2021 May 24;14(11):2792. doi: 10.3390/ma14112792

Figure 3.

Figure 3

Hemolysis produced by different AgNPs formulations in HDE. AgNP formulations were grouped as follows, considering the coating agents: (a) PVP, (b) citrate, (c) biogenic coating, and (d) starch. Label for each AgNPs formulation correspond to label employed in Table S2. For comparative purposes, the limits of no hemolysis (5%) and low hemolysis (10%) are shown with dotted blue horizontal lines.